Provided by Tiger Fintech (Singapore) Pte. Ltd.

Concert Pharmaceuticals

8.37
0.0000
Volume:- -
Turnover:90.16M
Market Cap:520.71M
PE:-2.69
High:8.37
Open:8.37
Low:8.37
Close:8.37
Loading ...

Company Profile

Company Name:
Concert Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.